Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Alzamend Neuro, Inc. Director's Dealing 2021

Jun 15, 2021

35321_dirs_2021-06-14_cdaa9f13-d9ca-4569-8783-309764fe25a1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Alzamend Neuro, Inc. (ALZN)
CIK: 0001677077
Period of Report: 2021-06-14

Reporting Person: McGrath Lynne Fahey (N/A)

More from Alzamend Neuro, Inc.

Proxy Solicitation & Information Statement 2026
Feb 26
Director's Dealing 2025
Dec 30
Director's Dealing 2025
Dec 23
Interim / Quarterly Report 2025
Dec 9
Board/Management Information 2025
Nov 18
Director's Dealing 2025
Oct 24
Regulatory Filings 2025
Oct 14
Director's Dealing 2025
Oct 10
Capital/Financing Update 2025
Oct 9
Director's Dealing 2025
Oct 8
View all filings →